Related Experiment Video
Updated: Jun 16, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Epidemiology and control of human gastrointestinal parasites in children
Michael O Harhay1, John Horton, Piero L Olliaro
1Graduate Group in Demography, Population Studies Center, University of Pennsylvania, 239 McNeil Building, 3718 Locust Walk, Philadelphia, PA 19104-16298, USA. harhay@pop.upenn.edu
Insights
Soil-transmitted helminths infect one-sixth of the global population, primarily children in low-income regions. Despite mass drug administration, many remain untreated, facing challenges like funding and drug resistance.
Area of Science:
- Global Health
- Infectious Diseases
- Parasitology
Background:
- Gastrointestinal parasites, including protozoa and helminths, disproportionately affect children in sub-Saharan Africa, Asia, and Latin America.
- Soil-transmitted helminths (STH) like Ascaris lumbricoides, hookworm, and Trichuris trichiura are the most prevalent, impacting an estimated one-sixth of the global population.
- Mass drug administration (MDA) programs, often school-based, have significantly increased anthelmintic drug delivery to children.
Purpose of the Study:
- To review the impact of major gastrointestinal protozoa and helminths on child health.
- To discuss the changing epidemiology of these infections.
- To analyze the relationship between epidemiology and control strategies.
Main Methods:
- Literature review of gastrointestinal protozoa and helminths.
- Analysis of epidemiological data and infection rates in children.
- Evaluation of current control strategies, including mass drug administration.
Main Results:
- MDA programs have delivered substantial quantities of anthelmintics but a large untreated population remains.
- Significant challenges hinder control efforts, including insufficient funding for research, drug procurement, and supply chain sustainability.
- Concerns exist regarding limited chemotherapy options, potential drug resistance due to overuse, and inadequate health infrastructure for monitoring.
Conclusions:
- While MDA is a powerful tool, substantial funding and resources are required to expand treatment coverage and address the growing untreated population.
- Developing novel treatments and second-line options is crucial to combat potential drug resistance.
- Strengthening health infrastructures is essential for effective pharmaco-epidemiology and monitoring of drug resistance.
Abstract:
Parasites found in the human gastrointestinal tract can be largely categorized into two groups, protozoa and helminths. The soil-transmitted helminths (Ascaris lumbricoides, hookworm and Trichuris trichiura) are the most prevalent, infecting an estimated one-sixth of the global population. Infection rates are highest in children living in sub-Saharan Africa, followed by Asia and then Latin America and the Caribbean. The current momentum towards global drug delivery for their control is at a historical high through the efforts of numerous initiatives increasingly acting in coordination with donors, governments and local communities. Together, they have delivered enormous quantities of drugs, especially anthelmintics to children through nationwide annual or biannual mass drug administration largely coordinated through schools. However, a much larger and rapidly growing childhood population in these regions remains untreated and suffering from more than one parasite. Mass drug administration has profound potential for control but is not without considerable challenges and concerns. A principal barrier is funding. Stimulating a research and development pipeline, supporting the necessary clinical trials to refine treatment, in addition to procuring and deploying drugs (and sustaining these supply chains), requires substantial funding and resources that do not presently exist. Limited options for chemotherapy raise concerns about drug resistance developing through overuse, however, satisfactory pharmaco-epidemiology and monitoring for drug resistance requires more developed health infrastructures than are generally available. Further, the limited pharmacopeia does not include any effective second-line options if resistance emerges, and the research and development pipeline is severely depressed. Herein, we discuss the major gastrointestinal protozoa and helminths reviewing their impact on child health, changing epidemiology and how this relates to their control.
Related Concept Videos
Giardiasis
Amebiasis
Malaria
Anthelminthic Agents
Fungal Phylum Microsporidia
Toxoplasmosis
